Company / Current Liabilities
Oruka Therapeutics, Inc. Current Liabilities History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$13.0M
FY2024
5-year range
$637.0K / $13.0M
FY2020-FY2024
Trend
+1947.6%
vs FY2023
Sector context
#202 of 213
Health Care
What the data says
Current Liabilities changed +1948% YoY in FY2024, a notable deviation from the 9-year average annual change of +235%.
Based on SEC 10-K filings.
$13M in FY2024 with a 5-year CAGR of +69.7%.
Increased from $1M to $13M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +55.1%
- 5-Year CAGR
- +69.7%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 213This company $13.0M Sector average $1.6B
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +69.7%, indicating consistent growth.
- In FY2024, current liabilities increased 1947.6% year-over-year.
- Ranks #202 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $13.0M | +1947.6% |
| FY2023 | $637.0K | -43.7% |
| FY2022 | $1.1M | -67.6% |
| FY2021 | $3.5M | -0.0% |
| FY2020 | $3.5M | +277.9% |
| FY2019 | $926.0K | +16.8% |
| FY2018 | $793.0K | -61.7% |
| FY2017 | $2.1M | -13.6% |
| FY2016 | $2.4M | +59.3% |
| FY2015 | $1.5M | +8.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026